Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy.

DE VITA, Salvatore

QUARTUCCIO, Luca

SCOTT, Cathryn Anne

Fabris M.